journal article·2021-12

An HSP90 inhibitor based fluorescent probe for selective tumor targeting

Shulei Zhu, Yingxin Lu, Jiyu Jin, Jiahui Yu, Wei Lu

Dyes and Pigments· Volume 196
Publisher page

Abstract

Abstract Fluorescent imaging has been widely used in the detection of diseases, especially cancer. Among them, biomarker-specific ligand-based imaging strategies have attracted much attention, due to their improved image contrast and diagnostic accuracy. In this work, an HSP90 inhibitor based fluorescent probe (Probe 1) was synthesized possessing the potential of selective tumor targeting, which was constructed with an HSP90 inhibitor and 4-hydroxy-1,8-naphthalimide derivative. Probe 2, a resorcinol-blocked probe was also synthesized as a control, which prevented binding with the HSP90 ATP binding pocket. Biological studies showed that Probe 1 could be selectively accumulated by tumor cells, while Probe 2 not, suggesting that Probe 1 is a promising targeted tumor imaging agent for early diagnosis.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Heat shock proteins research · ATP Synthase and ATPases Research · thermodynamics and calorimetric analyses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (35)

Show source-provided references
1. Integrin targeting for tumor optical imaging[J]10.7150/thno/v01p0102 ↗
2. In vivo optical imaging of cancer cell function and tumor microenvironment[J]10.1111/cas.13544 ↗
3. Beyond the margins: real-time detection of cancer using targeted fluorophores[J]10.1038/nrclinonc.2016.212 ↗
4. Bringing chemistry to life[J]10.1038/nmeth.1657 ↗
5. Imaging live-cell dynamics and structure at the single-molecule level[J]10.1016/j.molcel.2015.02.033 ↗
6. Molecular imaging of the tumor microenvironment[J]10.1016/j.addr.2016.07.012 ↗
7. In vivo imaging of cancer biomarkers using activatable molecular probes[J]10.3233/CBM-2008-4602 ↗
8. Aggregation-induced emission enhancement characteristics of naphthalimide derivatives and their applications in cell imaging[J]10.1039/c0jm02942d ↗
9. Design, synthesis and sensor activity of a highly photostable blue emitting 1, 8-naphthalimide[J]10.1016/j.jlumin.2012.04.023 ↗
10. The design, synthesis and photophysical properties of two novel 1, 8-naphthalimide fluorescent pH sensors based on PET and ICT[J]10.1016/j.dyepig.2010.08.004 ↗
11. Synthesis and fluorescent studies of a low molecular weight rotor for living cancer cell imaging[J]10.1016/j.dyepig.2020.108353 ↗
12. The synthesis and spectroscopic properties of novel, functional fluorescent naphthalimide dyes[J]10.1016/j.dyepig.2007.12.012 ↗
13. Synthesis and photophysical properties of some novel fluorescent dyes based on naphthalimide derivatives[J]10.1016/j.jphotochem.2010.09.004 ↗
14. Synthesis and bromination of 4-alkylamino-N-alkyl-1, 8-naphthalimides[J]10.1016/S0143-7208(99)00045-5 ↗
15. Recent conjugation strategies of small organic fluorophores and ligands for cancer-specific bioimaging[J]10.1016/j.cbi.2016.02.006 ↗
16. Site-specific, thiol-mediated conjugation of fluorescent probes to cysteine-modified diabodies targeting CD20 or HER2[J]10.1021/bc800113v ↗
17. Recent advances in ligand targeted therapy[J]10.3109/1061186X.2011.611518 ↗
18. Ligand-targeted drug delivery[J]10.1021/acs.chemrev.7b00013 ↗
19. A novel 2, 5-diaminopyrimidine-based affinity probe for Bruton's tyrosine kinase[J]10.1038/srep16136 ↗
20. Development of a selective labeling probe for Bruton's tyrosine kinase quantification in live cells[J]10.1021/acs.bioconjchem.8b00137 ↗
21. A fluorescent Hsp90 probe demonstrates the unique association between extracellular Hsp90 and malignancy in vivo[J]10.1021/acschembio.7b00006 ↗
22. Synthesis and evaluation of cell-permeable biotinylated PU-H71 derivatives as tumor Hsp90 probes[J]10.3762/bjoc.9.60 ↗
23. Optimized HSP90 mediated fluorescent probes for cancer-specific bioimaging[J]10.1039/C9TB02505G ↗
24. Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review[J]10.1186/s13550-021-00761-2 ↗
25. FAP‐Targeted photodynamic therapy mediated by ferritin nanoparticles elicits an immune response against cancer cells and cancer associated fibroblasts[J]10.1002/adfm.202007017 ↗
26. Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers[J]10.1007/s00259-020-04859-y ↗
27. A novel fibroblast activation protein-targeted near-infrared fluorescent off–on probe for cancer cell detection, in vitro and in vivo imaging[J]10.1039/C7TB03303F ↗
28. Synthesis and evaluation of 4-(2-hydroxypropyl) piperazin-1-yl) derivatives as Hsp90 inhibitors[J]10.1016/j.bmc.2016.03.049 ↗
29. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors[J]10.1038/nature01913 ↗
30. Inhibition of HSP90 molecular chaperones: moving into the clinic[J]10.1016/S1470-2045(13)70169-4 ↗
31. NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models[J]10.1186/bcr1996 ↗
32. Targeting heat shock proteins in cancer: a promising therapeutic approach[J]10.3390/ijms18091978 ↗
33. HSP90 as a new therapeutic target for cancer therapy: the story unfolds[J]10.1517/14712598.2.1.3 ↗
34. Targeting cell survival proteins for cancer cell death10.3390/ph9010011 ↗
35. HSP90 and co-chaperones: impact on tumor progression and prospects for molecular-targeted cancer therapy[J]10.1080/07357907.2020.1752227 ↗